Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers: insights from the ARISTOTLE trial.
Sandhu RK, Ezekowitz JA, Hijazi Z, Westerbergh J, Aulin J, Alexander JH, Granger CB, Halvorsen S, Hanna MS, Lopes RD, Siegbahn A, Wallentin L. Sandhu RK, et al. Among authors: aulin j. Open Heart. 2018 Nov 1;5(2):e000908. doi: 10.1136/openhrt-2018-000908. eCollection 2018. Open Heart. 2018. PMID: 30487982 Free PMC article.
Serial measurement of interleukin-6 and risk of mortality in anticoagulated patients with atrial fibrillation: Insights from ARISTOTLE and RE-LY trials.
Aulin J, Hijazi Z, Siegbahn A, Andersson U, Alexander JH, Connolly SJ, Ezekowitz MD, Gersh BJ, Granger CB, Horowitz J, Hylek EM, Lopes RD, Yusuf S, Wallentin L, Oldgren J. Aulin J, et al. J Thromb Haemost. 2020 Sep;18(9):2287-2295. doi: 10.1111/jth.14947. Epub 2020 Aug 1. J Thromb Haemost. 2020. PMID: 32510737 Free article.
Biomarkers and heart failure events in patients with atrial fibrillation in the ARISTOTLE trial evaluated by a multi-state model.
Aulin J, Hijazi Z, Lindbäck J, Alexander JH, Gersh BJ, Granger CB, Hanna M, Horowitz J, Lopes RD, McMurray JJV, Oldgren J, Siegbahn A, Wallentin L; ARISTOTLE Investigators. Aulin J, et al. Am Heart J. 2022 Sep;251:13-24. doi: 10.1016/j.ahj.2022.03.009. Epub 2022 May 13. Am Heart J. 2022. PMID: 35569564 Free article. Clinical Trial.
Serum Neurofilament Light Chain in Patients With Atrial Fibrillation.
Sjölin K, Aulin J, Wallentin L, Eriksson N, Held C, Kultima K, Oldgren J, Burman J. Sjölin K, et al. Among authors: aulin j. J Am Heart Assoc. 2022 Jul 19;11(14):e025910. doi: 10.1161/JAHA.122.025910. Epub 2022 Jul 15. J Am Heart Assoc. 2022. PMID: 35861814 Free PMC article.
Neurofilament Light Chain and Risk of Stroke in Patients With Atrial Fibrillation.
Aulin J, Sjölin K, Lindbäck J, Benz AP, Eikelboom JW, Hijazi Z, Kultima K, Oldgren J, Wallentin L, Burman J; ACTIVE A and AVERROES Investigators. Aulin J, et al. Circulation. 2024 Oct;150(14):1090-1100. doi: 10.1161/CIRCULATIONAHA.124.069440. Epub 2024 Jul 24. Circulation. 2024. PMID: 39045686 Clinical Trial.
Physical exercise for cytotoxic drug-induced fatigue.
Hartvig P, Aulin J, Wallenberg S, Wagenius G. Hartvig P, et al. Among authors: aulin j. J Oncol Pharm Pract. 2006 Dec;12(4):183-91. doi: 10.1177/1078155206070776. J Oncol Pharm Pract. 2006. PMID: 17156590 Clinical Trial.
Fatigue in cancer patients treated with cytotoxic drugs.
Hartvig P, Aulin J, Hugerth M, Wallenberg S, Wagenius G. Hartvig P, et al. Among authors: aulin j. J Oncol Pharm Pract. 2006 Sep;12(3):155-64. doi: 10.1177/1078155206070774. J Oncol Pharm Pract. 2006. PMID: 17022870